Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut

L Baglatzi1, S Gavrili1, K Stamouli1

  • 1Neonatal Department, Alexandra Hospital, University of Athens, Greece.

Insights

Supplementing infant formula with a low dose of Bifidobacterium lactis (B. lactis) probiotic showed similar immune and gut development benefits as a regular dose or breast milk. This supports the use of lower probiotic doses in infant formula for C-section born infants.

Area of Science:

  • Pediatric Nutrition
  • Microbiology
  • Immunology

Background:

  • Infant formula (IF) supplementation with probiotics aims to support immune functions and gut development in infants not breast-fed.
  • The probiotic Bifidobacterium lactis CNCM I-3446 (B. lactis) is commonly used in regular doses (10^7 CFU/g).

Purpose of the Study:

  • To evaluate if a low dose (10^4 CFU/g) of B. lactis in starter IF can achieve similar immune benefits as a regular dose.
  • To compare the effects of low-dose and regular-dose B. lactis IF with breast milk in C-section delivered infants.

Main Methods:

  • A pilot, prospective, double-blind, randomized clinical trial involving 77 infants per group receiving either low-dose or regular-dose B. lactis IF from birth to six months.
  • A reference group of 44 breast-fed infants (minimum 4 months) was included.
  • Assessments included gastrointestinal infections, immune and gut maturation, vaccination responses, and growth from birth to 12 months.

Main Results:

  • Low-dose B. lactis IF demonstrated comparable effects to regular-dose B. lactis IF and breast milk.
  • No significant differences were observed in gastrointestinal protection, immune/gut maturation, microbiota, or growth between the formula groups and the breast-fed group.

Conclusions:

  • Supplementing C-section born neonates with low-dose B. lactis starter formula may promote immune and gut maturation comparable to regular-dose B. lactis and breast milk.
  • This suggests that lower probiotic concentrations in infant formula can be effective.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
11
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
10
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
90.7K
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
50
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
31
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K